These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24016383)

  • 1. A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
    Aggarwal R; Guanci N; Marambage K; Caplan JP
    Psychosomatics; 2014; 55(4):404-408. PubMed ID: 24016383
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
    Yang SH; McNeely MJ
    Am J Psychiatry; 2002 Aug; 159(8):1435. PubMed ID: 12153844
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    Brieger P
    J Clin Psychiatry; 2004 Jan; 65(1):132-5. PubMed ID: 14744182
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 5. Ziprasidone-induced tardive dyskinesia.
    Mendhekar DN
    Can J Psychiatry; 2005 Aug; 50(9):567-8. PubMed ID: 16262114
    [No Abstract]   [Full Text] [Related]  

  • 6. Paliperidone-Induced Hyponatremia.
    Tibrewal P; Dhillon R; Sharma J; Bastiampillai T
    Prim Care Companion CNS Disord; 2017 Jul; 19(4):. PubMed ID: 28767207
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral Facial Dystonia (Meige or Brueghel Syndrome) Induced by Paliperidone Palmitate.
    Marques JG
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129491
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.
    Legrand G; Andrianarisoa M; Mauvieux J; Jalenques I
    J Clin Psychopharmacol; 2014 Oct; 34(5):652-3. PubMed ID: 25006816
    [No Abstract]   [Full Text] [Related]  

  • 9. Paliperidone-induced rhabdomyolysis: a case report.
    Fernández-Macho JG; Espárrago-Llorca G; Morales-Gómez GR; Guisado-Macías JA
    Actas Esp Psiquiatr; 2015; 43(2):66-8. PubMed ID: 25812544
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone and psychosis in Parkinson disease.
    Micheli F; Taubenslag N; Gatto E; Scorticati MC
    Clin Neuropharmacol; 2005; 28(5):254. PubMed ID: 16239772
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziprasidone and migraine headache.
    Boeker T
    Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziprasidone in the treatment of Parkinson's disease psychosis.
    Shiah IS; Lin CL; Mao WC; Luu SU
    Eur Psychiatry; 2006 Dec; 21(8):578-9. PubMed ID: 16139485
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic treatment of psychosis associated with multiple sclerosis.
    Davids E; Hartwig U; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):743-4. PubMed ID: 15276702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paliperidone Palmitate-Associated Severe Refractory Tardive Dyskinesia With Tardive Dystonia: Management and Six-Months Follow-Up.
    Singh S; Gupta A; Kuppili PP; Pattanayak RD; Khandelwal SK
    J Clin Psychopharmacol; 2016 Aug; 36(4):391-3. PubMed ID: 27269958
    [No Abstract]   [Full Text] [Related]  

  • 18. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of clinical observation: A case of subtle tardive dyskinesia with paliperidone palmitate.
    Omer HM; Thompson AD
    Aust N Z J Psychiatry; 2018 May; 52(5):496-497. PubMed ID: 29338294
    [No Abstract]   [Full Text] [Related]  

  • 20. A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis.
    Akkaya C; Sarandol A; Sivrioglu EY; Kotan Z; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1535-8. PubMed ID: 16820256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.